

An edition of Brain-disabling treatments in psychiatry (1997)
drugs, electroshock, and the role of the FDA
By Peter Roger Breggin
Publish Date
1997
Publisher
Springer Pub. Co.
Language
eng
Pages
426
Description:
subjects: Adverse effects, Brain, Brain damage, Chronic Brain Damage, Complications, Drug Industry, Effect of drugs on, Electroconvulsive therapy, Etiology, Iatrogenic diseases, Legislation, Mental Disorders, Psychotropic drugs, Side effects, Therapy, United States, United States. Food and Drug Administration, Electroconvulsive Therapy, Psychotropic Drugs, Hirnschadigung, Hersenbeschadiging, Psychopharmakon, Psychische Storung, Elektrokrampftherapie, Psychofarmaca, Arzneimittelnebenwirkung, Medizinschaden, Komplikation, Iatrogene ziekten, Elektroshocktherapie, United states, food and drug administration, Mental illness, treatment, Pharmaceutical industry, Brain chemistry, Public health & preventive medicine, Physician & patient, Pathology, Substance use & abuse - medical aspects, Pharmacology, Psychiatry - general & miscellaneous, The executive branch - general & miscellaneous
Places: United States